Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 10, 2020; 94 (10) Article

Increased mental health care use by mothers of children with multiple sclerosis

Ruth Ann Marrie, Julia O'Mahony, Colleen Maxwell, Vicki Ling, View ORCID ProfileE. Ann Yeh, Douglas L. Arnold, Amit Bar-Or, Brenda Banwell, for the Canadian Pediatric Demyelinating Disease Network
First published January 9, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008871
Ruth Ann Marrie
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia O'Mahony
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colleen Maxwell
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicki Ling
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Ann Yeh
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. Ann Yeh
Douglas L. Arnold
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Bar-Or
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Banwell
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Full PDF
Short Form
Citation
Increased mental health care use by mothers of children with multiple sclerosis
Ruth Ann Marrie, Julia O'Mahony, Colleen Maxwell, Vicki Ling, E. Ann Yeh, Douglas L. Arnold, Amit Bar-Or, Brenda Banwell, for the Canadian Pediatric Demyelinating Disease Network
Neurology Mar 2020, 94 (10) e1040-e1050; DOI: 10.1212/WNL.0000000000008871

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
125

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 94 no. 10 e1040-e1050
DOI: 
https://doi.org/10.1212/WNL.0000000000008871
PubMed: 
31919112

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 31, 2019
  • Accepted in final form September 8, 2019
  • First Published January 9, 2020.

Article Versions

  • Previous version (January 9, 2020 - 12:45).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Ruth Ann Marrie, MD, PhD,
    2. Julia O'Mahony, BSc,
    3. Colleen Maxwell, PhD,
    4. Vicki Ling, MSc,
    5. E. Ann Yeh, MD,
    6. Douglas L. Arnold, MD,
    7. Amit Bar-Or, MD,
    8. Brenda Banwell, MD;
    9. for the Canadian Pediatric Demyelinating Disease Network
  1. Ruth Ann Marrie, MD, PhD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Multiple Sclerosis Journal, Editorial Board Multiple Sclerosis Journal-ETC, Co-Editor

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. Received support as principal investigator from the Canadian Institutes of Health Research (2010-2019), and Research Manitoba (2014-2019).

    Research Support, Academic Entities:
    1. Waugh Family Chair in Multiple Sclerosis

    Research Support, Foundations and Societies:
    1. Received support as principal investigator from Multiple Sclerosis Society of Canada (2009-2019) and the National Multiple Sclerosis Society (2013-2018), and as co-principal investigator from Multiple Sclerosis Scientific Foundation (2009-2019). Received support from Consortium of Multiple Sclerosis Centers (2004-2009, 2011-2014, 2016-2017), Crohn's and Colitis Canada (2014- 2019)

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Julia O'Mahony, BSc,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Colleen Maxwell, PhD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Canadian Journal of Cardiology, Editorial Board Member, Nov 2007 to present. I have not received any compensation for my work on this board. Journal of Population Therapeutics and Clinical Pharmacology (formerly the Canadian Journal of Clinical Pharmacology), Associate Editor, May 2004 to present. I have not received any compensation for my work as an associate editor with this journal. Canadian Geriatrics Journal, Associate Editor, January 2014 to present. I have not received any compensation for my work on this board. Neuroepidemiology, Frontiers in Neurology, Review Editor, May 2019 - present. I have not received any compensation for my work on the editorial board.

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. (1) Queen's University Dean's Research Fund, Co- investigator, 2019-2020. (2) CIHR and Partners, Phase Two of the Canadian Consortium on Neurodegeneration in Aging (CCNA), Co-investigator, 2019- 2024. (3) Multiple Sclerosis Society of Canada, Co-investigator, 2019-2022. (4) Ontario Brain Institute Integrated Discovery Program, ONDRI-2, Aim 4, Co-investigator, 2018-2023. (5) Velux Stiftung, Co-investigator, 2018-2020. (6) Canadian Frailty Network 2018 Catalyst Grant (Cat2018- 01), Co-investigator, 2018-2019. (7) Queen's University, Co-investigator, 2018-2020. (8) Canadian Frailty Network, CAT2017-21, Principal Investigator, 2018-2019. (9) CIHR Project Grant, Co-investigator, 2018-2021. (10) P.S.I. Foundation, Co-investigator, 2017-2019. (11) Ontario Ministry of Health and Long Term Care - Health System Research Fund Program Award, Co- investigator, 2017-2021. (12) CIHR Catalyst Grant, Co-investigator, 2017-2018. (13) Multiple Sclerosis Society of Canada Operating Research Grant, Co-investigator, 2017-2019. (14) Consortium of Multiple Sclerosis Centers (CMSC) Pilot Grant, Co-investigator, 2016-2017. (15) CIHR Program Grant, Co-investigator, 2016-2021. (16) Canadian Frailty Network/TVN Strategic Impact Grant, Co-PI, 2014-2017. (17) CIHR Project Grant, Principal Investigator, 2014- 2017. (18) CIHR Project Grant, Co-investigator, 2014-2017. (19) CIHR - Canadian Consortium on Neurodegeneration in Aging (CCNA) Team Grant, Co-investigator, 2014-2019.

    Research Support, Academic Entities:
    1. (1) Queen's University (I am co-investigator on research grants being led by Dr. Dallas Seitz), 2018-2020. (2) Baycrest Centre for Geriatric Care (I am Co-investigator on Phase 2 of CCNA led by PI at Baycrest), 2019-2024. (3) University of Calgary (I am Co-investigator on several grants led by Dr. Kirsten Fiest), 2018-2021. (4) University of Waterloo (I am Co-investigator on several research grants), 2017-2020.

    Research Support, Foundations and Societies:
    1. Physician Services Incorporated (P.S.I) Foundation. Multiple Sclerosis Scientific Research Foundation.

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Vicki Ling, MSc,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. E. Ann Yeh, MD,
  10. Scientific Advisory Boards:
    1. I perform MS relapse adjudication for ACI services on a fee-for-service basis. Juno therapeutics scientific advisory board 2017 Biogen, scientific advisory board 2019

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Neurology, editorial advisory board, 2013-present. MSJ editorial board 2016-present BMC Neurology editorial board 2016-present PLOS-One: Editorial board, 2018-present

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Biogen, funding for investigator-initiated research.

    Research Support, Government Entities:
    1. 1) CIHR, Co-I. PI: Pohl 2) PCORI, Co-I, CE-1304-7079 3) CMSMS (CIHI/PHAC), MS Monitoring system pilot funding 4)SCN: co-PI, 2015-present 5)OIRM, co-PI, 2015-present, PI, 2019-present

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. 1) National MS Society HC 0148 2) National MS Society PP2256 3) MS Society (Canada) 4) Dairy Farmers of Ontario 5) SickKids Innovation Fund 6) MS Research Foundation (Canada) 7) Rare Diseases Foundation

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Douglas L. Arnold, MD,
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. Acorda Therapeutics, Biogen, Celgene, GeNeuro, Genentech, F. Hoffmann-La Roche, Merck, Novartis, Roche, Sanofi, Teva, Wave Life Sciences

    Speakers' Bureaus:
    1. NONE

    Other activities:
    1. NeuroRx Research, President

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. Biogen, Immunotec, Novartis

    Research Support, Government Entities:
    1. CIHR, MSSC

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. International Progressive MS Alliance

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Amit Bar-Or, MD,
  14. Scientific Advisory Boards:
    1. Receptos-Celgene, Advisor, Scientific Board, 2011 - Sanofi/Genzyme, Advisor, Scientific board, 2017 - Roche/Genentech, Advisor, Scientific Board, 2008- Novartis, Advisor, Scientific Board, 2012- GSK, Advisor 2012 - 2014 Atara Therapeutics, Advisor, Scientific Board, 2017 - Guthy Jackson Greater Good Foundation, Scientific Advisor, 2008- Immune Tolerance Network - Steering Committee, 2016 -

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. Receptos-Celgene, Advisor, Scientific Board, 2011 - Roche/Genentech, Advisor, Scientific Board, 2008- Novartis, Advisor, Scientific Board, 2012- Sanofi-Genzyme 2015- GSK, Advisor 2012 - 2014

    Editorial Boards:
    1. (1) Neurology, Editorial Board Member, 2008-2015 (2) Clinical and Experimental Neuroimmunology, Editorial Board Member, 2010 -

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. Receptos-Celgene, Advisor, Scientific Board, 2011 - Roche/Genentech, Advisor, Scientific Board, 2008- Novartis, Advisor, Scientific Board, 2012- Sanofi-genzyme - Advisor, 2015 - GSK, Advisor 2012 - 2014 Atara Therapeutics, Advisor, Scientific Board, 2017 -

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Novartis (2) Genzyme-Sanofi (3) Biogen

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  15. Brenda Banwell, MD;
  16. Scientific Advisory Boards:
    1. Scientific Advisory Board, Biogen-IDEC, Sanofi, Eli Lilly, Novartis.

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. Novartis

    Editorial Boards:
    1. I serve on the Editorial Board for Neurology. I receive no financial remuneration.

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. I have served as a consultant to Novartis.

    Speakers' Bureaus:
    1. I have spoken at an event supported by the Consortium of MS Centers, the Corpus, and Medscape

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. Multiple Sclerosis Society of Canada Multiple Sclerosis Scientific Research Foundation National Multiple Sclerosis Society

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  17. for the Canadian Pediatric Demyelinating Disease Network
  1. From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Institute of Health Policy, Management and Evaluation (J.O.) and Division of Neurology, Neurosciences and Mental Health, SickKids Research Institute (E.A.Y.), The Hospital for Sick Children, University of Toronto; Schools of Pharmacy and Public Health and Health Systems (C.M.), University of Waterloo; ICES (C.M., V.L.), Toronto; Department of Pediatrics (E.A.Y.), University of Toronto; Montreal Neurological Institute (D.L.A.), McGill University, Montreal, Canada; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology (A.B.-O.), Perelman School of Medicine, University of Pennsylvania; and Division of Child Neurology (B.B.), The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  1. Correspondence
    Dr. Marrie rmarrie{at}hsc.mb.ca
View Full Text

Article usage

Article usage: January 2020 to December 2022

AbstractFullPdfSource
Jan 2020517028Highwire
Feb 202015509Highwire
Mar 20206314029Highwire
Apr 202014012Highwire
May 20206436Highwire
Jun 202011045Highwire
Jul 20205821Highwire
Aug 20203634Highwire
Sep 20209667Highwire
Oct 20206724Highwire
Nov 20204410Highwire
Dec 20206800Highwire
Jan 20215134Highwire
Feb 20214042Highwire
Mar 20214843Highwire
Apr 20217300Highwire
May 20215055Highwire
Jun 20213422Highwire
Jul 20215330Highwire
Aug 20213422Highwire
Sep 20213800Highwire
Oct 20217711Highwire
Nov 20214613Highwire
Dec 20213912Highwire
Jan 20223112Highwire
Feb 20224300Highwire
Mar 20223900Highwire
Apr 202210281Highwire
May 20222800Highwire
Jun 20226800Highwire
Jul 20222601Highwire
Aug 20223111Highwire
Sep 20221510Highwire
Oct 20223121Highwire
Nov 20225210Highwire
Dec 20224900Highwire

Cited By...

  • 5 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study funding
    • Disclosure
    • Appendix 1 Authors
    • Appendix 2 Coinvestigators
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Health Services Research
  • All Psychiatric disorders
  • All Medical/Systemic disease
  • Multiple sclerosis
  • Cohort studies

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise